Discover 1,943 paid clinical trials in Fort Worth, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Fort Worth offers a range of medical research opportunities, focusing on conditions such as cancer, cardiovascular disease, PTSD, and COVID-19. Healthy volunteers looking for paid opportunities, as well as those with specific health concerns, can participate in studies at the city’s leading healthcare facilities, gaining access to new and innovative treatments while contributing to advancements in medical research.
Filter
2
Filter results
Results: 1,943
New
A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies
for
Advanced Solid Tumors, Colorectal Cancer (CRC),
Location: Dallas TX, Austin TX, San Antonio TX, Nashville TN,
Sponsor: Kumquat Biosciences Inc.
Sex: All
Age: 18+
Code: NCT07542704
Phase 1, Recruiting
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
for
Advanced or Metastatic Solid Tumor
Location: Fort Worth TX, Austin TX, Grand Rapids MI,
Sponsor: Pliant Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06270706
Phase 1, Recruiting
First In Human Study of CX-801 in Advanced Solid Tumors
for
Solid Tumor, Adult
Location: Fort Worth TX, Englewood CO, Nashville TN,
Sponsor: CytomX Therapeutics
Sex: All
Age: 18+
Code: NCT06462794
Phase 1, Recruiting
A Study of IDP-001 in Advanced or Metastatic Solid Tumors
for
Advanced Solid Tumor, Metastatic Solid Tumor,
Location: Fort Worth TX, Indianapolis IN, Sarasota FL,
Sponsor: InduPro, Inc.
Sex: All
Age: 18+
Code: NCT07602842
Phase 1, Phase 2, Recruiting
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
for
Esophageal Squamous Cell Carcinoma,
Location: Fort Worth TX, Irving TX, Austin TX, San Antonio TX,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18+
Code: NCT07503808
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
for
Small Cell Lung Cancer Metastatic or Locally Advanced,
Location: Dallas TX, San Antonio TX, Houston TX, New Orleans LA,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT07080242
Phase 1, Recruiting
A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors
for
Cancer
Location: Fort Worth TX, Dallas TX, Austin TX, San Antonio TX,
Sponsor: IDEAYA Biosciences
Sex: All
Age: 18 - 70+
Code: NCT07540572
Phase 1, Recruiting
First In Human Study of CX-2051 in Advanced Solid Tumors
for
Solid Tumor, Adult
Location: Fort Worth TX, San Antonio TX, Denver CO, Nashville TN,
Sponsor: CytomX Therapeutics
Sex: All
Age: 18+
Code: NCT06265688
Phase 1, Recruiting
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Fort Worth TX, Tyler TX, Austin TX, San Antonio TX,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT06136559
Phase 3, Recruiting
Multi-Institutional Registry for Prostate Cancer Radiosurgery
for
Prostate Cancer Early Risk Treated by Radiosurgery,
Location: Fort Worth TX, Dallas TX, Tyler TX, Austin TX,
Sponsor: RPCR, Inc.
Sex: Male
Age: 18 - 70+
Code: NCT01226004
Recruiting
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Location: Fort Worth TX, San Antonio TX, Houston TX, St Louis MO,
Sponsor: Verastem, Inc.
Sex: All
Age: 18+
Code: NCT07644559
Phase 2, Recruiting
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
for
Non Small Cell Lung Cancer (Squamous or Non Squamous),
Location: Fort Worth TX, Albuquerque NM, Pueblo CO, Daphne AL,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18+
Code: NCT07365319
Phase 2, Phase 3, Recruiting
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
for
Non-small Cell Lung Cancer (NSCLC)
Location: Fort Worth TX, Denton TX, Tyler TX, Austin TX,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07361497
Phase 3, Recruiting
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
for
Solid Tumor, Small Cell Lung Cancer (SCLC),
Location: Fort Worth TX, West Valley City UT, Los Angeles CA
Sponsor: Exscientia AI Ltd., a wholly owned subsidiary of Recursion Pharmaceuticals, Inc.
Sex: All
Age: 18+
Code: NCT07517198
Phase 1, Recruiting
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
for
Breast Neoplasms
Location: Arlington TX, Fort Worth TX, Burleson TX,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07173751
Phase 3, Recruiting
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
for
HER2-positive Breast Cancer
Location: Fort Worth TX, Austin TX, Germantown TN, Huntsville AL,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07413939
Phase 2, Phase 3, Recruiting
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
for
Advanced Solid Tumors, MSI-H or dMMR Advanced Solid Tumors,
Location: Fort Worth TX, Houston TX, Plantation FL, Tamarac FL,
Sponsor: Eikon Therapeutics
Sex: All
Age: 18+
Code: NCT07262619
Phase 1, Phase 2, Recruiting
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
for
Colorectal Cancer
Location: Fort Worth TX, Grapevine TX, Austin TX, Houston TX,